Morphea developing at the site of healed herpes zoster

Annals of Dermatology

Volumn 23, Issue 2, 2011, Pages 242-245

  Noh, Tae Woo ^a   Park, Sang Hoon ^a   Kang, Yoo Seok ^a   Lee, Un Ha ^a   Park, Hyun Su ^a   Jang, Sang Jai ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Herpes zoster; Morphea; Scleroderma; Wolf's isotopic response

Indexed keywords

EID: 79958758262     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2011.23.2.242     Document Type: Article

References (23)

1. Requena L, Kutzner H, Escalonilla P, Ortiz S, Schaller J, Rohwedder A. Cutaneous reactions at sites of herpes zoster scars: an expanded spectrum. BrJ Dermatol 1998;138:161-168. (Pubitemid 28077957)
2. Ruocco V, Ruocco E, Ghersetich I, Bianchi B, Lotti T. Isotopic response after herpesvirus infection: an update. J Am Acad Dermatol 2002;46:90-94. (Pubitemid 34073483)
3. Wolf R, Brenner S, Ruocco V, Filioli FG. Isotopic response. Int J Dermatol 1995;34:341-348.
4. Zimmermann H. Zoster as a premorbid state of a circumscribed scleroderma. Dermatol Wochenschr 1964;150:112-116.
5. Forschner A, Metzler G, Rassner G, Fierlbeck G. Morphea with features of lichen sclerosus et atrophicus at the site of a herpes zoster scar: another case of an isotopic response, Int J Dermatol 2005;44:524-525.
6. López N, Alcaraz I, Cid-Mañas J, Camacho E, Herrera-Acosta E, Matilla A, et al. Wolf's isotopic response: zosteriform morphea appearing at the site of healed herpes zoster in a HIV patient. J Eur Acad Dermatol Venereol 2009;23:90-92.
7. Serfling U, Penneys NS, Zhu WY, Sisto M, Leonardi C. Varicella-zoster virus DNA in granulomatous skin lesions following herpes zoster. A study by the polymerase chain reaction. J Cutan Pathol 1993;20:28-33. (Pubitemid 23092867)
8. Claudy AL, Chignol MC, Chardonnet Y. Detection of herpes simplex virus DNA in a cutaneous squamous cell carcinoma by in situ hybridization. Arch Dermatol Res 1989,281:333-335. (Pubitemid 19222017)
9. Lotti T, Hautmann G, Panconesi E. Neuropeptides in skin. J Am Acad Dermatol 1995;33:482-496.
10. Vancheeswaran R, Black CM, David J, Hasson N, Harper J, Atherton D, et al. Childhood-onset scleroderma: is it different from adult-onset disease. Arthritis Rheum 1996; 39:1041-1049. (Pubitemid 26182075)
11. Aberer E, Neumann R, Stanek G. Is localised scleroderma a Borrelia infection? Lancet 1985;2:278. (Pubitemid 15047579)
12. Hasegawa M, Sato S, Nagaoka T, Fujimoto M, Takehara K. Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma. Dermatology 2003;207:141-147. (Pubitemid 37034341)
13. Sedgwick JD, Riminton DS, Cyster JG, Körner H. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol Today 2000;21:110-113. (Pubitemid 30122696)
14. Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15:19-26.
15. Burd PR, Thompson WC, Max EE, Mills FC. Activated mast cells produce interleukin 13. J Exp Med 1995;181:1373-1380.
16. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995;70:1068-1076.
17. Joly P, Bamberger N, Crickx B, Belaich S. Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients. Arch Dermatol 1994;130: 663-664. (Pubitemid 24150954)
18. Eist EF, Van Suijlekom-Smit LW, Oranje AP. Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children. Pediatr Dermatol 1999;16: 53-58. (Pubitemid 29102635)
19. Mancuso G, Berdondini RM. Localized scleroderma: response to occlusive treatment with tacrolimus ointment. Br J Dermatol 2005;152:180-182.
20. Dytoc M, Ting PT, Man J, Sawyer D, Fiorillo L. First case series on the use of imiquimod for morphoea. Br J Dermatol 2005;153:815-820. (Pubitemid 41415912)
21. Grundmann-Kollmann M, Ochsendorf F, Zollner TM, Spieth K, Sachsenberg-Studer E, Kaufmann R, et al. PUVA-cream photochemotherapy for the treatment of localized scleroderma. J Am Acad Dermatol 2000;43:675-678.
22. El-Mofty M, Zaher H, Bosseila M, Yousef R, Saad B. Low-dose broad-band UVA in morphea using a new method for evaluation. Photodermatol Photoimmunol Photomed 2000; 16:43-49. (Pubitemid 30230383)
23. El-Mofty M, Mostafa W, El-Darouty M, Bosseila M, Nada H, Yousef R, et al. Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis. Photodermatol Photoimmunol Photomed 2004;20:148-156. (Pubitemid 38744933)